Jump to content
  • Sign Up
Scott Adams

First Startup From Avalon-Gsk Deal Raises $10M For Celiac Disease - Xconomy

Rate this topic

Recommended Posts

First Startup from Avalon-GSK Deal Raises $10M for Celiac Disease

Xconomy

Avalon partner Jay Lichter says the company, Sitari Pharmaceuticals, was recently established with $10 million in Series A financing, provided under the Avalon-GSK partnership, to develop new treatments for celiac disease. Under their innovative ...

View the full article

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


×
×
  • Create New...